Zepbound
Zepbound is tirzepatide made by Eli Lilly and approved by the FDA for weight management. Three of the five providers here publish a price.
| Provider | Price | Plan and terms | Availability | Visit provider |
|---|---|---|---|---|
| Sesame CareZepbound® KwikPen | $299a month, continuing | Weekly injectionMedication billed separately | All 50 statesPrice checked 2 August 2026 | Visit |
| GobyMedsZepbound® | $1,399a month, continuing | Weekly injection | All 50 statesPrice checked 31 July 2026 | Visit |
| Sprout HealthZepbound® | $1,999a month, continuing | Weekly injection | Not available in Alabama, Arkansas, Louisiana, Mississippi and North DakotaPrice checked 2 August 2026 | Visit |
| Oak LongevityZepbound® | Not publishedquoted after intake | Weekly injectionMedication billed separately | All 50 statesNo price published | Visit |
| WellorithmZepbound® | Not publishedquoted after intake | Weekly injectionMedication billed separately | All 50 statesNo price published | Visit |
Reading these prices
Sesame Care lists $299 for the visit, with the medication billed on top. GobyMeds lists $1,399 and Sprout Health lists $1,999, and both of those cover the drug. Read the included column before comparing the numbers. Eli Lilly also sells some doses direct to patients, which can beat a telehealth price outright.
What is not in this table
Prices here come from each company’s own public pages on the date shown in the availability column. A clinician sets the dose after an intake questionnaire, and the dose can change what you pay. Shipping, lab work, and follow-up visits are charged separately by some companies. Telehealth Ledger does not prescribe or dispense medication and does not decide whether a treatment suits you.